A systematic mapping of funders of maternal health intervention research 2000–2012

Globalization and Health

Loveday Penn-Kekana⁶  Francisco Becerra⁵  Elinor Kern⁶  Emily Vargas⁷  Leon Bijlmakers³  Siphiwe Thwala⁶  Mari Dumbaugh⁴  Josephine Kavanagh¹  Ashar Dhana⁶  Oona MR Campbell²  Duane Blaauw⁶  Matthew Chersich⁸  Katharine Footman² 

[1] Department of Childhood, Families and Health, Institute of Education, 20 Bedford Way, London WC1H 0AL, UK;Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK;Radboud University Medical Center, Department of Epidemiology, Biostatistics and Health Technology Assessment (HEV), Nijmegen, The Netherlands;Independent Consultant, World Health Organization, Geneva, Switzerland;Pan American Health Organization, 525 Twenty-third Street, N.W., Washington 20037, D.C., USA;Centre for Health Policy, Faculty of Health Sciences, University of Witwatersrand, Johannesburg 2000, South Africa;Centre for Health Systems Research, National Institute of Public Health, Colonia Santa María Ahuacatitlán, Cerrada Los Pinos y Caminera, Cuernavaca, C.P. 62100, México;Wits Reproductive Health and HIV research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg 2000, South Africa

关键词: Research and development;    Evidence;    Priorities;    Maternal health;    Funding;    Research;   

Others  :  1133884
DOI  :  10.1186/s12992-014-0072-x

 received in 2014-03-27, accepted in 2014-09-19,  发布年份 2014

【 摘 要 】

Background

The priorities of research funding bodies govern the research agenda, which has important implications for the provision of evidence to inform policy. This study examines the research funding landscape for maternal health interventions in low- and middle-income countries (LMICs).

Methods

This review draws on a database of 2340 academic papers collected through a large-scale systematic mapping of research on maternal health interventions in LMICs published from 2000–2012. The names of funders acknowledged on each paper were extracted and categorised into groups. It was noted whether support took a specific form, such as staff fellowships or drugs. Variations between funder types across regions and topics of research were assessed.

Results

Funding sources were only reported in 1572 (67%) of articles reviewed. A high number of different funders (685) were acknowledged, but only a few dominated funding of published research. Bilateral funders, national research agencies and private foundations were most prominent, while private companies were most commonly acknowledged for support ‘in kind’. The intervention topics and geographic regions of research funded by the various funder types had much in common, with HIV being the most common topic and sub-Saharan Africa being the most common region for all types of funder. Publication outputs rose substantially for several funder types over the period, with the largest increase among bilateral funders.

Conclusions

A considerable number of organisations provide funding for maternal health research, but a handful account for most funding acknowledgements. Broadly speaking, these organisations address similar topics and regions. This suggests little coordination between funding agencies, risking duplication and neglect of some areas of maternal health research, and limiting the ability of organisations to develop the specialised skills required for systematically addressing a research topic. Greater transparency in reporting of funding is required, as the role of funders in the research process is often unclear.

【 授权许可】

   
2014 Footman et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Sridhar D: Who sets the global health research agenda? The challenge of multi-bi financing. PLoS Med 2012, 9(9):e1001312.
• [2]Lee K, Mills A: Strengthening governance for global health research. BMJ 2000, 321(7264):775-6. PubMed PMID: 11009495. Pubmed Central PMCID: 1118594
• [3]World Health Organization. Research and development to meet health needs in developing countries: strengthening global financing and coordination: report of the consultative expert working group on research and development: financing and coordination. 2012.
• [4]Leroy JL, Habicht J-P, Pelto G, Bertozzi SM: Current priorities in health research funding and lack of impact on the number of child deaths per year. Am J Public Health 2007, 97(2):219-23.
• [5][http://www.cohred.org/publications/open-archive/1990-commission-report/] webcite Commission on Health Research for Development: Health Research: Essential Link to Equity in Development. 1990. Available from:
• [6]Shiffman J: A social explanation for the rise and fall of global health issues. Bull WHO 2009, 87(8):608-13.
• [7]Shiffman J: Has donor prioritization of HIV/AIDS displaced aid for other health issues? Health Policy Plan 2008, 23(2):95-100.
• [8]Sridhar D, Batniji R: Misfinancing global health: a case for transparency in disbursements and decision making. Lancet 2008, 372(9644):1185-91.
• [9]Pokhrel S, Reidpath D, Allotey P: Social sciences research in neglected tropical diseases 3: Investment in social science research in neglected diseases of poverty: a case study of Bill and Melinda Gates Foundation. Health Res Policy Syst 2011, 9(1):2. BioMed Central Full Text
• [10]Moran M, Guzman J, Ropars A-L, McDonald A, Jameson N, Omune B, Ryan S, Wu L: Neglected disease research and development: how much are we really spending? PLoS Med 2009, 6(2):e1000030.
• [11]Pitt C, Greco G, Powell-Jackson T, Mills A: Countdown to 2015: assessment of official development assistance to maternal, newborn, and child health, 2003–08. Lancet 2010, 376(9751):1485-96.
• [12]Financing Global Health 2009: Tracking Development Assistance for Health. IHME, Seattle, WA; 2009.
• [13]Gough D, Thomas J, Oliver S: Clarifying differences between review designs and methods. Syst Rev 2012, 1(1):28. BioMed Central Full Text
• [14]Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, Gonzalez-Medina D, Barber R, Huynh C, Dicker D, Templin T, Wolock TM, Ozgoren AA, Abd-Allah F, Abera SF, Achoki T, Adelekan A, Ademi Z, Adou AK, Adsuar JC, Agardh EE, Akena D, Alasfoor D, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Al Kahbouri MJ, Alla F, Allen PJ, et al.: Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study. Lancet 2014, 384(9947):980-1004. PubMed PMID: 24797575
• [15]Global Health Visions: U.S Maternal Health Donors: A Landscape Analysis. Global Health Visions. 2011.
• [16][http://www.rdmag.com/sites/rdmag.com/files/gff-2014-5_7%20875x10_0.pdf] webcite Battelle: Global R&D funding forecast.R&D Magazine 2014. .
• [17]Rottingen JA, Regmi S, Eide M, Young AJ, Viergever RF, Ardal C, Guzman J, Edwards D, Matlin SA, Terry RF: Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory? Lancet 2013, 382(9900):1286-307. PubMed PMID: 23697824
• [18]Fisk NM, McKee M, Atun R: Relative and absolute addressability of global disease burden in maternal and perinatal health by investment in R&D. Trop Med Int Health 2011, 16(6):662-8. PubMed PMID: 21470349
• [19]Fisk NM, Atun R: Systematic analysis of research underfunding in maternal and perinatal health. BJOG 2009, 116(3):347-56. PubMed PMID: 19187366
• [20][http://www.policycures.org/g-finder2012.html] webcite G-Finder: Neglected disease research and development: a five year review.Policy Cures 2012. Available from:
• [21]Moran M, Guzman J, Ropars AL, McDonald A, Jameson N, Omune B, Ryan S, Wu L: Neglected disease research and development: how much are we really spending? PLoS Med 2009, 6(2):e30. PubMed PMID: 19192946. Pubmed Central PMCID: 2634791
• [22]Macroeconomics and Health: Investing in Health for Economic Development. World Health Organization, Geneva; 2001.
• [23]McCoy D, Kembhavi G, Patel J, Luintel A: The Bill & Melinda Gates Foundation's grant-making programme for global health. Lancet 2009, 373(9675):1645-53.
• [24][http://www.who.int/phi/cewg/en/] webcite Secretariat: Consultative Expert Working Group on Research and Development: Financing and Coordination. 2012. Available from:
• [25]Viergever RF: The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions. Global Health Action 2013, 6:22450. PubMed PMID: 24119660. Pubmed Central PMCID: 3796018
• [26]McCoy D, Chand S, Sridhar D: Global health funding: how much, where it comes from and where it goes. Health Policy Plan 2009, 24(6):407-17.
• [27]Vartanian LR, Schwartz MB, Brownell KD: Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. Am J Public Health 2007, 97(4):667-75.
• [28]Levine J, Gussow J, Hastings D, Eccher A: Authors’ financial relationships with the food and beverage industry and their published positions on the fat substitute olestra. Am J Public Health 2003, 93:664-9.
• [29]What has the Gates Foundation done for global health? Lancet 2009, 373:1577.
• [30]Stuckler D, Basu S, McKee M: Global health philanthropy and institutional relationships: how should conflicts of interest be addressed? PLoS Med 2011, 8(4):e1001020.
• [31]von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Prev Med 2007, 45:247-251.